Tests a pre-transplant exercise and diet program in older adults with myeloma
Tests exercise and diet before stem cell transplant in adults 60 or older with myeloma.
Key facts
- Who runs it
- Noha Mohamed Sharafeldin
- Where
- Birmingham, United StatesSee the site
- Trial code
- Registry title
- Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 10 Jul 2023
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Multi-modal Exercise Regimen
- Dietary Guidelines
- Record updated
- 24 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 60 or older with multiple myeloma who are scheduled for an autologous stem cell transplant at UAB. It tests a program to prepare the body before the transplant.
- Age
- 60 years or older
- Sex
- All sexes can join
- Disease stage
- Multiple myeloma, scheduled for an autologous stem cell transplant (ASCT) at UAB within 10 weeks of joining
Main reasons for not taking part
- High risk of an impending pathologic fracture (bone break), judged with the Mirels score
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Diagnosis of Multiple Myeloma
- Scheduled for ASCT at UAB within 10 weeks of study enrollment
- age at ASCT ≥60y
Who cannot take part
- at high risk for impending pathologic fracture using Mirels score
Where in United States
- Kirklin Clinic of UAB HospitalBirmingham, United StatesContact: Landon Martin, BSTaking people
About the trial
What the trial wants to find out
This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.
The 2 groups in the trial
- TeleprehabTreatment being tested
The participants selected for the teleprehab arm will undergo a supervised 8-week multi-modal exercise program in a telehealth format (using doxy.me, a free telehealth platform) delivered by licensed physical or occupational therapists who have undergone cancer specific rehabilitation training within Select Medical's ReVital® cancer rehabilitation program. Participants will attend teleprehab sessions 2 times per week for a total of 16 sessions.
Treatment: Multi-modal Exercise Regimen and Dietary Guidelines
- Attention ControlOther group
The participants randomized to the attention control arm will not undergo an exercise regimen, but will be contacted by the study staff on the phone once a week..
Treatment: Dietary Guidelines
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cell Transplant
- Plain-language title
- Tests a pre-transplant exercise and diet program in older adults with myelomaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 24 December 2025